» Articles » PMID: 17131933

The Role of Cytokines in the Immune Response to Influenza A Virus Infection

Overview
Journal Acta Virol
Specialty Microbiology
Date 2006 Nov 30
PMID 17131933
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A virus is one of the most important causes of respiratory tract diseases. It replicates in epithelial cells and leukocytes resulting in the production of immune mediators--cytokines, substances with various biological effects. Cytokines, as a part of innate immunity, favor the development of antiviral and TH 1-type immune responses. Cytokines also affect the adaptive immune response and disease manifestation. In the organism, the virus infection results in the production of chemotactic [a regulated upon activation, normal T cell-expressed and -secreted cytokine (RANTES), monocyte chemoattractant proteins (MCP) MCP-1, MCP-3, macrophage inflammatory protein 1 alpha (MIP- 1 alpha), interferon gamma-induced protein 10 (IP-10), and interleukin 8 (IL-8)], pro-inflammatory [IL- 1beta, IL-6, IL-18, and tumor necrosis factor alpha(TNF-alpha)] and antiviral [interferon (IFN) alpha/beta] cytokines. Whilst knowledge of the mechanisms underlying host and tissue specificity has advanced significantly, we still know relatively little about the function of cytokines released from different cells following influenza infection. In this review we deal with the role and mode of possible impact of cytokines on the disease pathogenesis and host immune response.

Citing Articles

Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer.

Meissner R, Wixler V, Wulfert F, Jacob J, Hale B, Robeck T Mol Ther Oncolytics. 2023; 31:100741.

PMID: 38020062 PMC: 10679949. DOI: 10.1016/j.omto.2023.100741.


Multi-omics data integration reveals the complexity and diversity of host factors associated with influenza virus infection.

Zhu Z, You R, Li H, Feng S, Ma H, Tuo C PeerJ. 2023; 11:e16194.

PMID: 37842064 PMC: 10569165. DOI: 10.7717/peerj.16194.


Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects.

Zhang C, Tu Y, Sun X, Chen D, Zhang W, Zhuang C Front Immunol. 2022; 13:856327.

PMID: 35296098 PMC: 8918788. DOI: 10.3389/fimmu.2022.856327.


Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.

Peter A, Sandeep B, Rao B, Kalpana V Front Pharmacol. 2021; 11:583777.

PMID: 33708109 PMC: 7941276. DOI: 10.3389/fphar.2020.583777.


Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.

Wyganowska-Swiatkowska M, Nohawica M, Grocholewicz K, Nowak G Int J Mol Sci. 2020; 21(13).

PMID: 32629817 PMC: 7370028. DOI: 10.3390/ijms21134639.